heblaj01
01-02-2007, 01:22 PM
http://www.breastcancerupdate.com/download-audio/bcu/2006/8/default.asp
Several interesting comments including speculation on the potential for high response to the Herceptin+Tykerb combo based on preclinical & early clinical results ( track 17 of Interview with Lisa Carey, MD and Jenny C Chang, MD:
Potential synergy between trastuzumab and lapatinib (http://www.breastcancerupdate.com/download-audio/bcu/2006/8/BCU8_06_Chang/17_BCU8_06_Chang.mp3))
Also track 13:Receptor cross talk and potential changes in ER or HER2 phenotype (http://www.breastcancerupdate.com/download-audio/bcu/2006/8/BCU8_06_Chang/13_BCU8_06_Chang.mp3)
(http://www.breastcancerupdate.com/download)
Several interesting comments including speculation on the potential for high response to the Herceptin+Tykerb combo based on preclinical & early clinical results ( track 17 of Interview with Lisa Carey, MD and Jenny C Chang, MD:
Potential synergy between trastuzumab and lapatinib (http://www.breastcancerupdate.com/download-audio/bcu/2006/8/BCU8_06_Chang/17_BCU8_06_Chang.mp3))
Also track 13:Receptor cross talk and potential changes in ER or HER2 phenotype (http://www.breastcancerupdate.com/download-audio/bcu/2006/8/BCU8_06_Chang/13_BCU8_06_Chang.mp3)
(http://www.breastcancerupdate.com/download)